132 related articles for article (PubMed ID: 20731664)
1. Nucleotide-binding domain of phosphoglycerate kinase 1 reduces tumor growth by suppressing COX-2 expression.
Ho MY; Tang SJ; Ng WV; Yang W; Leu SJ; Lin YC; Feng CK; Sung JS; Sun KH
Cancer Sci; 2010 Nov; 101(11):2411-6. PubMed ID: 20731664
[TBL] [Abstract][Full Text] [Related]
2. Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
Tang SJ; Ho MY; Cho HC; Lin YC; Sun GH; Chi KH; Wang YS; Jhou RS; Yang W; Sun KH
Int J Cancer; 2008 Dec; 123(12):2840-8. PubMed ID: 18814280
[TBL] [Abstract][Full Text] [Related]
3. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
[TBL] [Abstract][Full Text] [Related]
4. Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.
Shetty S; Ganachari M; Liu MC; Azghani A; Muniyappa H; Idell S
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L591-8. PubMed ID: 15951330
[TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
6. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines.
Takemoto N; Serada S; Fujimoto M; Honda H; Ohkawara T; Takahashi T; Nomura S; Inohara H; Naka T
Oncotarget; 2015 May; 6(13):11009-22. PubMed ID: 25826092
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
10. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
[TBL] [Abstract][Full Text] [Related]
11. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.
Lam W; Bussom S; Cheng YC
Mol Cancer Ther; 2009 Feb; 8(2):415-23. PubMed ID: 19208827
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics.
Nian WQ; Chen FL; Ao XJ; Chen ZT
Mol Cell Biochem; 2011 Sep; 355(1-2):241-8. PubMed ID: 21553023
[TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
15. Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-κB.
Zhu X; Gu J; Qian H
Arch Bronconeumol (Engl Ed); 2018 Mar; 54(3):128-133. PubMed ID: 29108761
[TBL] [Abstract][Full Text] [Related]
16. TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression of TGF-β1 and IL-10 and tumor cells migration.
Li C; Li H; Jiang K; Li J; Gai X
Biomed Mater Eng; 2014; 24(1):869-75. PubMed ID: 24211974
[TBL] [Abstract][Full Text] [Related]
17. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
18. Specific overexpression of 15-lipoxygenase in endothelial cells promotes cancer cell death in an in vivo Lewis lung carcinoma mouse model.
Sultan M; Ben-Shushan D; Peled M; Kamari Y; Isman S; Barshack I; Kuban RJ; Kühn H; Harats D; Shaish A
Adv Med Sci; 2020 Mar; 65(1):111-119. PubMed ID: 31923770
[TBL] [Abstract][Full Text] [Related]
19. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Mathew B; Lennon FE; Siegler J; Mirzapoiazova T; Mambetsariev N; Sammani S; Gerhold LM; LaRiviere PJ; Chen CT; Garcia JG; Salgia R; Moss J; Singleton PA
Anesth Analg; 2011 Mar; 112(3):558-67. PubMed ID: 21156980
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo.
Natsume T; Koh Y; Kobayashi M; Fukumoto H; Takahashi F; Nakamura T; Ohe Y; Saijo N; Nishio K
Cancer Chemother Pharmacol; 2002 Jan; 49(1):35-47. PubMed ID: 11855751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
